The Nrf2-ARE Signalling Pathway: Promising Drug Target to Combat Oxidative Stress in Neurodegenerative Disorders

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|4|3|267-281

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.4, Iss.3, 2005-06, pp. : 267-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regression of Oxidative Stress by Targeting eNOS and Nrf2/ARE Signaling: A Guided Drug Target for Cardiovascular Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 9, 2015-05 ,pp. : 857-871

Bentham Science Publishers

Access to resources Recommend Favorite

The Hedgehog signaling pathway – implications for drug targets in cancer and neurodegenerative disorders

By Bak Mads   Hansen Claus   Tommerup Niels   Larsen Lars Allan  

Pharmacogenomics, Vol. 4, Iss. 4, 2003-07 ,pp. : 411-429

Future Medicine

Access to resources Recommend Favorite

Recent updates on the dynamic association between oxidative stress and neurodegenerative disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 3, 2016-04 ,pp. : 310-320

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear Factor Erythroid 2 - Related Factor 2 Signaling in Parkinson Disease: A Promising Multi Therapeutic Target Against Oxidative Stress, Neuroinflammation and Cell Death

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 8, 2012-12 ,pp. : 1015-1029

Bentham Science Publishers

Access to resources Recommend Favorite

MenA Is a Promising Drug Target for Developing Novel Lead Molecules to Combat Mycobacterium tuberculosis

By  

Medicinal Chemistry, Vol. 5, Iss. 2, 2009-03 ,pp. : 197-207

Bentham Science Publishers

Access to resources Recommend Favorite